https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/available-for-sale-gross-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/buybacks-form-sc-to-i https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/increase-decrease-in-restricted-cash-and-investments https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/interest-and-other-income https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/interest-income-other https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/license-costs https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/litigation-reserve-noncurrent https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/litigation-settlement-expense https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/other-assets-miscellaneous-current https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/postconfirmation-additional-paid-in-capital https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/security-deposit https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/somaxon-pharmaceuticals-inc/warrants-not-settleable-in-cash-fair-value-disclosure